CELGENE CORP (CELG) Stock Price, Forecast & Analysis
USA - NASDAQ:CELG -
CELG Key Statistics, Chart & Performance
The current stock price of CELG is 108.24 null. In the past month the price increased by 3.1%. In the past year, price increased by 62.4%.
CELG Latest News, Press Relases and Analysis
About CELG
Company Profile
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID, ABRAXANE, OTEZLA, ISTODAX and IDHIFA. The drug candidates in their pipeline are at various stages of preclinical and clinical development. These candidates include their IMiDs compounds, which are a proprietary class of compounds that have certain immunomodulatory and other biologically important properties in addition to their leading oral anti-inflammatory agents and cellular therapies. They believe their commercial stage products and the depth of their product pipeline, provide the catalysts for future growth.
Company Info
CELGENE CORP
86 MORRIS AVENUE
SUMMIT NJ 07901
CEO: Mark J. Alles
Phone: 908-673-9000
CELGENE CORP / CELG FAQ
What does CELG do?
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID, ABRAXANE, OTEZLA, ISTODAX and IDHIFA. The drug candidates in their pipeline are at various stages of preclinical and clinical development. These candidates include their IMiDs compounds, which are a proprietary class of compounds that have certain immunomodulatory and other biologically important properties in addition to their leading oral anti-inflammatory agents and cellular therapies. They believe their commercial stage products and the depth of their product pipeline, provide the catalysts for future growth.
What is the current price of CELG stock?
The current stock price of CELG is 108.24 null. The price increased by 0.1% in the last trading session.
Does CELG stock pay dividends?
CELG does not pay a dividend.
What is the ChartMill technical and fundamental rating of CELG stock?
CELG has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the PE ratio for CELG stock?
The PE ratio for CELGENE CORP (CELG) is 11. This is based on the reported non-GAAP earnings per share of 9.84 and the current share price of 108.24 null.
CELG Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to CELG. When comparing the yearly performance of all stocks, CELG is one of the better performing stocks in the market, outperforming 94.89% of all stocks.
CELG Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to CELG. CELG has an excellent profitability rating, but there are some minor concerns on its financial health.
CELG Financial Highlights
Over the last trailing twelve months CELG reported a non-GAAP Earnings per Share(EPS) of 9.84. The EPS increased by 33.51% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 34.62% | ||
| ROA | 14.22% | ||
| ROE | 48.65% | ||
| Debt/Equity | 1.51 |